| 摘要 |
<p>The invention relates to the use of known 2-phenyl substituted imidazotriazinones having short, unbranched alkyl radicals in the 9 position and cGMP-PDE-inhibiting properties for the production of medicaments to treat heart insufficiency, psoriasis, female infertility, cancer, diabetes, eye diseases such as glaucoma, disorders of stomach movement, cystic fibrosis, premature contractions, pulmonary high blood pressure, bladder diseases, prostatic hyperplasia, nitrate-induced tolerance, preeclampsia, alopecia, Parkinson's disease, pain, tinnitus or renal syndrome.</p> |
